Samarth Kulkarni
2016
In 2016, Samarth Kulkarni earned a total compensation of $1.3M as Chief Executive Officer at CRISPR Therapeutics AG.
Compensation breakdown
| Non-Equity Incentive Plan | $135,360 |
|---|---|
| Option Awards | $822,706 |
| Salary | $352,046 |
| Other | $1,052 |
| Total | $1,311,164 |
Kulkarni received $822.7K in option awards, accounting for 63% of the total pay in 2016.
Kulkarni also received $135.4K in non-equity incentive plan, $352K in salary and $1.1K in other compensation.
Rankings
In 2016, Samarth Kulkarni's compensation ranked 6,917th out of 14,075 executives tracked by ExecPay. In other words, Kulkarni earned more than 50.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,917 out of 14,075 | 51st |
Division Manufacturing | 2,599 out of 5,489 | 53rd |
Major group Chemicals And Allied Products | 847 out of 1,895 | 55th |
Industry group Drugs | 651 out of 1,538 | 58th |
Industry Biological Products, Except Diagnostic Substances | 116 out of 279 | 58th |
Source: SEC filing on April 30, 2019.
Kulkarni's colleagues
We found three more compensation records of executives who worked with Samarth Kulkarni at CRISPR Therapeutics AG in 2016.
News
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2021 pay jumps 87% to $17M
April 25, 2022
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2020 pay falls 44% to $9.1M
April 28, 2021
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2019 pay jumps 67% to $16M
April 24, 2020
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2018 pay jumps 40% to $9.7M
April 30, 2019